Currently, there are 170.14M common shares owned by the public and among those 121.12M shares have been available to trade.
The company’s stock has a 5-day price change of -16.79% and 14.81% over the past three months. QBTS shares are trading 13.45% year to date (YTD), with the 12-month market performance up to 2.93% higher. It has a 12-month low price of $0.57 and touched a high of $2.44 over the same period. QBTS has an average intraday trading volume of 3.94 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.23%, -0.24%, and -21.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of D-Wave Quantum Inc (NYSE: QBTS) shares accounts for 24.42% of the company’s 170.14M shares outstanding.
It has a market capitalization of $197.34M and a beta (3y monthly) value of 0.95. The earnings-per-share (ttm) stands at -$0.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.97% over the week and 11.03% over the month.
Earnings per share for the fiscal year are expected to increase by 22.55%, and 12.69% over the next financial year.
Looking at the support for the QBTS, a number of firms have released research notes about the stock. B. Riley Securities stated their Buy rating for the stock in a research note on July 25, 2024, with the firm’s price target at $3. Needham coverage for the D-Wave Quantum Inc (QBTS) stock in a research note released on April 08, 2024 offered a Buy rating with a price target of $2.50. Piper Sandler was of a view on October 19, 2022 that the stock is Overweight, while ROTH Capital gave the stock Buy rating on August 30, 2022, issuing a price target of $20.
